BRIEF published on 04/25/2024 at 18:05, 1 year 7 months ago VoltAero Begins Certification Tests for Hybrid-Electric Powertrain of Cassio 330 Aircraft Aerospace Technology VoltAero Electric-hybrid Aircraft Cassio 330 Certification Testing
BRIEF published on 04/25/2024 at 18:05, 1 year 7 months ago VoltAero commence les tests de certification pour le groupe motopropulseur hybride-électrique de l'avion Cassio 330 Technologie Aérospatiale VoltAero Cassio 330 Avion Hybride Électrique Tests De Certification
PRESS RELEASE published on 04/25/2024 at 18:00, 1 year 7 months ago VoltAero Initiates Certification Testing for the Electric-Hybrid Powertrain to Equip Its Cassio 330 Aircraft VoltAero's Cassio 330 e-aircraft undergoes certification testing for electric-hybrid powertrain, combining Safran Electrical & Power's motor and Kawasaki engine VoltAero Cassio 330 Certification Testing Electric-hybrid Powertrain Aircraft Development
Published on 12/05/2025 at 02:35, 4 hours 46 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 21 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 16 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 21 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 21 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 3 hours 50 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 30 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 55 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 6 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:14, 13 hours 6 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 13 hours 21 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 13 hours 21 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 36 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 13 hours 36 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
